AGP
CME icon

Aspire Growth Partners’s CME Group CME Stock Holding History

Aspire Growth Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Sell
2,117
-236
-10% -$65.3K 0.27% 71
2026
Q1 		$695K Buy
2,353
+5
+0.2% +$1.49K 0.48% 49
2025
Q4 		$641K Sell
2,348
-126
-5% -$34.2K 0.45% 49
2025
Q3 		$669K Buy
2,474
+11
+0.4% +$2.99K 0.49% 46
2025
Q2 		$679K Sell
2,463
-512
-17% -$139K 0.56% 43
2025
Q1 		$847K Buy
2,975
+616
+26% +$152K 0.75% 34
2024
Q4 		$548K Buy
+2,359
New +$542K 0.54% 48

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Aspire Growth Partners's CME Position: Q2 2026 in Review

Aspire Growth Partners reduced its CME Group (CME) stake by 10% in Q2 2026, selling an estimated $65.3K and leaving 2,117 shares worth $467K. The position accounts for 0.27% of the portfolio, ranked #71.

Aspire Growth Partners first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $847K in Q1 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Aspire Growth Partners held 2,117 shares of CME Group worth $467K as of Q2 2026.
  • Aspire Growth Partners sold 236 CME Group shares in Q2 2026, an estimated $65.3K.
  • CME Group made up 0.27% of Aspire Growth Partners's portfolio in Q2 2026, its #71 holding.
  • Aspire Growth Partners first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Aspire Growth Partners's CME Group position peaked at $847K in Q1 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.